Meyer N - Search Results

1

Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.

Chartrain M, Riond J, Stennevin A, Vandenberghe I, Gomes B, Lamant L, Meyer N, Gairin JE, Guilbaud N, Annereau JP. Chartrain M, et al. Among authors: meyer n. PLoS One. 2012;7(5):e36762. doi: 10.1371/journal.pone.0036762. Epub 2012 May 24. PLoS One. 2012. PMID: 22675422 Free PMC article.

2

The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors.

Delmas A, Cherier J, Pohorecka M, Medale-Giamarchi C, Meyer N, Casanova A, Sordet O, Lamant L, Savina A, Pradines A, Favre G. Delmas A, et al. Among authors: meyer n. Oncotarget. 2015 Jun 20;6(17):15250-64. doi: 10.18632/oncotarget.3888. Oncotarget. 2015. PMID: 26098773 Free PMC article.

3

CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans.

Thomas-Pfaab M, Annereau JP, Munsch C, Guilbaud N, Garrido I, Paul C, Brousset P, Lamant L, Meyer N. Thomas-Pfaab M, et al. Among authors: meyer n. J Dermatol Sci. 2013 Feb;69(2):105-13. doi: 10.1016/j.jdermsci.2012.11.003. Epub 2012 Nov 10. J Dermatol Sci. 2013. PMID: 23219141

4

Highly Concordant Results Between Immunohistochemistry and Molecular Testing of Mutated V600E BRAF in Primary and Metastatic Melanoma.

Manfredi L, Meyer N, Tournier E, Grand D, Uro-Coste E, Rochaix P, Brousset P, Lamant L. Manfredi L, et al. Among authors: meyer n. Acta Derm Venereol. 2016 Jun 15;96(5):630-4. doi: 10.2340/00015555-2326. Acta Derm Venereol. 2016. PMID: 26695089 Free article.

5

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1.

Imbert C, Montfort A, Fraisse M, Marcheteau E, Gilhodes J, Martin E, Bertrand F, Marcellin M, Burlet-Schiltz O, Peredo AG, Garcia V, Carpentier S, Tartare-Deckert S, Brousset P, Rochaix P, Puisset F, Filleron T, Meyer N, Lamant L, Levade T, Ségui B, Andrieu-Abadie N, Colacios C. Imbert C, et al. Among authors: meyer n. Nat Commun. 2020 Jan 23;11(1):437. doi: 10.1038/s41467-019-14218-7. Nat Commun. 2020. PMID: 31974367 Free PMC article.

6

Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect.

Negulescu M, Deilhes F, Sibaud V, Tournier E, Lamant L, Boulinguez S, Meyer N. Negulescu M, et al. Among authors: meyer n. Case Rep Dermatol. 2017 Mar 21;9(1):80-85. doi: 10.1159/000461571. eCollection 2017 Jan-Apr. Case Rep Dermatol. 2017. PMID: 28611627 Free PMC article.

7

Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.

Armand-Labit V, Meyer N, Casanova A, Bonnabau H, Platzer V, Tournier E, Sansas B, Verdun S, Thouvenot B, Hilselberger B, Doncescu A, Lamant L, Lacroix-Triki M, Favre G, Pradines A. Armand-Labit V, et al. Among authors: meyer n. Acta Derm Venereol. 2016 Jan;96(1):29-34. doi: 10.2340/00015555-2156. Acta Derm Venereol. 2016. PMID: 26039581 Free article.

8

Acute skin reaction suggestive of pembrolizumab-induced radiosensitization.

Sibaud V, David I, Lamant L, Resseguier S, Radut R, Attal J, Meyer N, Delord JP. Sibaud V, et al. Among authors: meyer n. Melanoma Res. 2015 Dec;25(6):555-8. doi: 10.1097/CMR.0000000000000191. Melanoma Res. 2015. PMID: 26312439

9

Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.

Montfort A, Bertrand F, Rochotte J, Gilhodes J, Filleron T, Milhès J, Dufau C, Imbert C, Riond J, Tosolini M, Clarke CJ, Dufour F, Constantinescu AA, Junior NF, Garcia V, Record M, Cordelier P, Brousset P, Rochaix P, Silvente-Poirot S, Therville N, Andrieu-Abadie N, Levade T, Hannun YA, Benoist H, Meyer N, Micheau O, Colacios C, Ségui B. Montfort A, et al. Among authors: meyer n. Cancer Immunol Res. 2021 May;9(5):568-582. doi: 10.1158/2326-6066.CIR-20-0342. Epub 2021 Mar 16. Cancer Immunol Res. 2021. PMID: 33727246 Free PMC article.

10

Ultrarapid lytic granule release from CTLs activates Ca²⁺-dependent synaptic resistance pathways in melanoma cells.

Filali L, Puissegur MP, Cortacero K, Cussat-Blanc S, Khazen R, Van Acker N, Frenois FX, Abreu A, Lamant L, Meyer N, Vergier B, Müller S, McKenzie B, Valitutti S. Filali L, et al. Among authors: meyer n. Sci Adv. 2022 Feb 18;8(7):eabk3234. doi: 10.1126/sciadv.abk3234. Epub 2022 Feb 16. Sci Adv. 2022. PMID: 35171665 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,288 results

Search Page